EPA’s New Drinking-Water Screen Looks Beyond the Usual Suspects — Microplastics Stay on the Research List
Share
According to Environmental Protection coverage of an agency announcement (~Sep 9–10, 2026), EPA scientists will use non-targeted analysis to screen drinking water for pharmaceuticals, PFAS, and more than 1,000 potential contaminants that targeted methods can miss. Findings are meant to help guide future drinking-water research priorities under the Safe Drinking Water Act. Read the trade brief: EPA launches study to screen drinking water for more than 1,000 potential contaminants.
The study sits alongside EPA’s draft Sixth Contaminant Candidate List (CCL6) (spring 2026), which — for the first time in that process — identifies microplastics and pharmaceuticals as priority contaminant groups for research, data collection, and funding related to unregulated contaminants. That is research prioritization, not a nationwide microplastics maximum contaminant level (MCL).
In June, EPA also proposed the Sixth Unregulated Contaminant Monitoring Rule (UCMR6), which would require monitoring for 30 unregulated contaminants using existing approved methods. Agency framing: the non-targeted study is intended to fill gaps that CCL and UCMR processes do not fully cover.
Why this matters for WaterVo readers
If you followed WaterVo’s earlier CCL / UCMR explainers, treat this as a sequel: EPA is still building the evidence ladder for unknowns — including microplastics as a research priority group — while household source choices remain a separate, practical conversation. Atmospheric water generation is one option that does not start from municipal pipe water; we do not claim it replaces regulation or “beats” EPA science.
Read the Environmental Protection brief →
Editorial note: WaterVo News summarizes agency and trade reporting. Microplastics on draft CCL6 = research priority language in coverage — not a finished nationwide MCL. Soft claims only.